357580 — Amosense Co Balance Sheet
0.000.00%
- KR₩95bn
- KR₩143bn
- KR₩134bn
- 38
- 54
- 72
- 57
Annual balance sheet for Amosense Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15,638 | 14,610 | 17,410 | 10,016 | 3,521 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,516 | 14,185 | 12,874 | 26,196 | 34,235 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31,565 | 45,334 | 56,434 | 71,147 | 73,805 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19,405 | 19,993 | 20,308 | 23,439 | 26,425 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 59,037 | 76,209 | 90,796 | 111,164 | 123,796 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 33,095 | 33,297 | 28,020 | 65,450 | 52,016 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 45,950 | 42,326 | 53,179 | 74,719 | 82,388 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 13,087 | 33,883 | 37,617 | 36,445 | 41,408 |
| Total Liabilities & Shareholders' Equity | 59,037 | 76,209 | 90,796 | 111,164 | 123,796 |
| Total Common Shares Outstanding |